Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.5 RB, SLActive? 10mm, RXD: medical device reports filed with FDA

4,454 reports name it, 2020–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,454
device reports naming the brand
0% of all MAUDE reports · about 686 a year
1,186
reports, 12 months to August 2026
1,025 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,454 reports that name the brand "BLX ?3.5 RB, SLActive? 10mm, RXD" (endosseous dental implant), received between January 2020 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,186 reports arrived in the 12 months to August 2026, up 16% from 1,025 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73.1%), loss of osseointegration (16.7%) and difficult to insert (1%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0103205Sep 2021: 22Oct 2021: 25Nov 2021: 48Dec 2021: 362022Jan 2022: 35Feb 2022: 46Mar 2022: 25Apr 2022: 57May 2022: 63Jun 2022: 18Jul 2022: 46Aug 2022: 54Sep 2022: 55Oct 2022: 64Nov 2022: 41Dec 2022: 532023Jan 2023: 60Feb 2023: 64Mar 2023: 57Apr 2023: 90May 2023: 61Jun 2023: 50Jul 2023: 54Aug 2023: 72Sep 2023: 58Oct 2023: 50Nov 2023: 63Dec 2023: 712024Jan 2024: 56Feb 2024: 69Mar 2024: 81Apr 2024: 75May 2024: 99Jun 2024: 62Jul 2024: 72Aug 2024: 58Sep 2024: 72Oct 2024: 117Nov 2024: 120Dec 2024: 992025Jan 2025: 77Feb 2025: 61Mar 2025: 74Apr 2025: 48May 2025: 0Jun 2025: 205Jul 2025: 80Aug 2025: 72Sep 2025: 83Oct 2025: 122Nov 2025: 81Dec 2025: 992026Jan 2026: 80Feb 2026: 78Mar 2026: 143Apr 2026: 92May 2026: 90Jun 2026: 101Jul 2026: 119Aug 2026: 98

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05011,0022020: 9620202021: 26820212022: 55720222023: 75020232024: 98020242025: 1,00220252026: 8012026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,454
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report79.2%3,529
Voluntary report0%0
User facility report0%0
Distributor report20.8%925
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,25573.1%62.8%
Loss of osseointegration74516.7%22.4%
Difficult to insertthe device was hard to insert431%0.4%
Fracturea broken bone110.2%1.6%
Separation failure60.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,52334.2%
Painpain, site not specified84118.9%
Inflammationinflammation2696%
Hemorrhage/blood loss/bleeding2044.6%
Swelling/ edema1994.5%
Hyperresponsive to stimuli1373.1%
Fistula1062.4%
Abscessa collection of pus872%
Hypersensitivity/allergic reaction511.1%
Tissue damage390.9%
Inadequate osseointegration110.2%
Sinus perforation80.2%
Failure of implant60.1%
Numbnessnumbness60.1%
Corneal stromal edema10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.5 RB, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports4,4543,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer79.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.5 RB, SLActive? 10mm, RXD reports

How many FDA reports name BLX ?3.5 RB, SLActive? 10mm, RXD?

4,454 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,186 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73.1%), loss of osseointegration (16.7%), difficult to insert (1%), fracture (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (79.2%) and distributor reports (20.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.5 RB, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.